Allosteric Coupling in Homomeric Cys-loop Receptors

同聚 Cys 环受体中的变构偶联

基本信息

  • 批准号:
    7448472
  • 负责人:
  • 金额:
    $ 32.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-07-15 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Neurotransmitter receptors of the Cys-loop superfamily mediate fast synaptic transmission throughout the central and peripheral nervous systems. Their essential task is to transduce binding of neurotransmitter into opening of an intrinsic ion channel, yet the mechanism by which this transduction is achieved remains unknown. This proposal aims to delineate two fundamental facets of the transduction mechanism in homomeric Cys-loop receptors: (1) the number of agonist binding sites and binding-pore coupling regions required for activation by the agonist and (2) the structural basis for coupling agonist binding to channel gating. The proposed studies take advantage of the relative structural simplicity of homomeric receptors, employ a novel method for generating receptors with prescribed numbers of intact binding sites and coupling regions, and build on our recent demonstration that a network of interdependent loops functionally couples ligand binding and pore domains. The experiments combine expression of chimeric and non-chimeric receptors in mammalian cells, measurements of single channel current amplitudes and dwell times, measurements of ionic currents following rapid application of agonist, site-directed mutagenesis, and structural modeling of receptors. The approaches developed will allow the transduction mechanism to be addressed in all types of Cys-loop receptors, while the overall insights will advance our understanding of how post-synaptic receptors function in health, disease and in the presence of therapeutic drugs. Lay description: Cys-loop receptors relay signals from cell to cell throughout the nervous system, and are implicated in a wide variety of diseases, such as myasthenia, hyperekplexia, epilepsy, and nicotine addiction. They are also targets for drugs used clinically, such as muscle relaxants, anxiolytics, and anticonvulsants. Knowledge of how Cys-loop receptors operate at the molecular level is essential to developing therapeutic strategies and drugs with fewer side effects.
描述(由申请人提供):Cys-环超家族的神经递质受体介导整个中枢和外周神经系统的快速突触传递。它们的基本任务是将神经递质的结合转化为内在离子通道的开放,然而实现这种转导的机制仍然未知。该提议旨在描述同型半胱氨酸环受体中转导机制的两个基本方面:(1)激动剂激活所需的激动剂结合位点和结合孔偶联区域的数量,以及(2)偶联激动剂结合通道门控的结构基础。拟议的研究利用同源受体的相对结构简单,采用了一种新的方法,用于产生受体与规定数量的完整的结合位点和耦合区域,并建立在我们最近的演示,一个网络的相互依赖的循环功能耦合配体结合和孔域。这些实验结合了哺乳动物细胞中嵌合和非嵌合受体的联合收割机表达、单通道电流幅度和停留时间的测量、激动剂快速应用后离子电流的测量、定点诱变和受体的结构建模。开发的方法将允许在所有类型的Cys环受体中解决转导机制,而整体见解将促进我们对突触后受体在健康,疾病和治疗药物存在下如何发挥作用的理解。 铺设说明:半胱氨酸环受体在整个神经系统中从细胞到细胞传递信号,并且与多种疾病有关,例如肌无力、过度兴奋、癫痫和尼古丁成瘾。它们也是临床上使用的药物的靶点,例如肌肉松弛剂、抗焦虑药和抗惊厥药。了解Cys环受体如何在分子水平上运作对于开发具有较少副作用的治疗策略和药物至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Steven M Sine其他文献

Steven M Sine的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Steven M Sine', 18)}}的其他基金

Mechanism of calcium potentiation of alpha7 nicotinic receptors
α7烟碱受体钙增强机制
  • 批准号:
    9296195
  • 财政年份:
    2016
  • 资助金额:
    $ 32.33万
  • 项目类别:
MOD THE STRUCT & DYN OF NICOTINIC ACETYLCHOLINE RECEPTORS:
修改结构
  • 批准号:
    8169358
  • 财政年份:
    2010
  • 资助金额:
    $ 32.33万
  • 项目类别:
MOD THE STRUCT & DYN OF NICOTINIC ACETYLCHOLINE RECEPTORS:
修改结构
  • 批准号:
    7955280
  • 财政年份:
    2009
  • 资助金额:
    $ 32.33万
  • 项目类别:
DETECTION OF ACH-MEDIATED CONFORMATIONAL CHANGES OF ACHBP
ACH介导的ACHBP构象变化的检测
  • 批准号:
    7598788
  • 财政年份:
    2007
  • 资助金额:
    $ 32.33万
  • 项目类别:
Allosteric Coupling in Homomeric Cys-loop Receptors
同聚 Cys 环受体中的变构偶联
  • 批准号:
    7150190
  • 财政年份:
    2006
  • 资助金额:
    $ 32.33万
  • 项目类别:
Allosteric Coupling in Homomeric Cys-loop Receptors
同聚 Cys 环受体中的变构偶联
  • 批准号:
    7261248
  • 财政年份:
    2006
  • 资助金额:
    $ 32.33万
  • 项目类别:
Allosteric Coupling in Homomeric Cys-loop Receptors
同聚 Cys 环受体中的变构偶联
  • 批准号:
    7638630
  • 财政年份:
    2006
  • 资助金额:
    $ 32.33万
  • 项目类别:
MOLECULAR DETERMINANTS OF ACETYLCHOLINE RECEPTOR GATING
乙酰胆碱受体门控的分子决定因素
  • 批准号:
    2908322
  • 财政年份:
    1999
  • 资助金额:
    $ 32.33万
  • 项目类别:
MOLECULAR DETERMINANTS OF ACETYLCHOLINE RECEPTOR GATING
乙酰胆碱受体门控的分子决定因素
  • 批准号:
    6394967
  • 财政年份:
    1999
  • 资助金额:
    $ 32.33万
  • 项目类别:
MOLECULAR DETERMINANTS OF ACETYLCHOLINE RECEPTOR GATING
乙酰胆碱受体门控的分子决定因素
  • 批准号:
    6188816
  • 财政年份:
    1999
  • 资助金额:
    $ 32.33万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 32.33万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 32.33万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 32.33万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 32.33万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 32.33万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 32.33万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 32.33万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 32.33万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 32.33万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 32.33万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了